Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 121

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 121
---
 not currently contemplated due to events that may occur as a result of, or in connection with, these actions. 

36

Results of Operations

Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Net sales$333.1 $333.8 $912.5 $936.8 Cost of sales199.2 202.2 538.8 571.9 Gross profit133.9 131.6 373.7 364.9 Selling, general, and administrative expenses44.1 37.9 129.6 119.5 Research and technical expenses7.0 6.2 21.0 18.0 Restructuring and other (income) charges, net1.0 3.3 10.1 8.3 Goodwill impairment charge— — 183.8 306.6 Acquisition-related costs— (0.1)— — Other (income) expense, net1.2 6.5 9.5 7.8 Interest expense, net18.4 23.8 56.4 69.3 Income (loss) from continuing operations before income taxes62.2 54.0 (36.7)(164.6)Provision (benefit) for income taxes on continuing operations21.4 6.5 34.8 (23.6)Net income (loss) from continuing operations40.8 47.5 (71.5)(141.0)Income (loss) from discontinued operations, net of income taxes2.7 (154.7)(11.0)(305.9)Net income (loss)$43.5 $(107.2)$(82.5)$(446.9)

Q3 2025 Performance Summary

Net sales were flat to the prior year. Increased Net sales in the Performance Chemicals reportable segment's road technologies product line and Performance Materials reportable segment was offset by lower volumes in Advanced Polymer Technologies due to the indirect impact of tariffs.

Net sales

The table below shows the 2025 Net sales and variances from 2024:Change vs. prior yearIn millionsPrior year Net salesVolumePrice/MixCurrency effectCurrent year Net salesThree months ended September 30, 2025 vs. 2024$333.8 (1.4)(